KR20080008321A - 국소 젤 조성물 - Google Patents

국소 젤 조성물 Download PDF

Info

Publication number
KR20080008321A
KR20080008321A KR1020077022557A KR20077022557A KR20080008321A KR 20080008321 A KR20080008321 A KR 20080008321A KR 1020077022557 A KR1020077022557 A KR 1020077022557A KR 20077022557 A KR20077022557 A KR 20077022557A KR 20080008321 A KR20080008321 A KR 20080008321A
Authority
KR
South Korea
Prior art keywords
composition
nsaid
prodrug
solvent
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020077022557A
Other languages
English (en)
Korean (ko)
Inventor
모니크 스팬-웨이드
안쏘니 제이. 워드
Original Assignee
아이에스더블유 그룹, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/361,384 external-priority patent/US20070053984A1/en
Application filed by 아이에스더블유 그룹, 인크. filed Critical 아이에스더블유 그룹, 인크.
Publication of KR20080008321A publication Critical patent/KR20080008321A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020077022557A 2005-03-03 2006-02-27 국소 젤 조성물 Withdrawn KR20080008321A (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US65808405P 2005-03-03 2005-03-03
US60/658,084 2005-03-03
US68110205P 2005-05-13 2005-05-13
US60/681,102 2005-05-13
US69020105P 2005-06-14 2005-06-14
US60/690,201 2005-06-14
US11/361,384 US20070053984A1 (en) 2005-03-03 2006-02-24 Topical gels compositions
US11/361,384 2006-02-24

Publications (1)

Publication Number Publication Date
KR20080008321A true KR20080008321A (ko) 2008-01-23

Family

ID=42334238

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077022557A Withdrawn KR20080008321A (ko) 2005-03-03 2006-02-27 국소 젤 조성물

Country Status (10)

Country Link
EP (1) EP1858503B1 (enExample)
JP (1) JP2008531693A (enExample)
KR (1) KR20080008321A (enExample)
AU (1) AU2006220964A1 (enExample)
BR (1) BRPI0608077A2 (enExample)
CA (1) CA2599968A1 (enExample)
ES (1) ES2437201T3 (enExample)
IL (1) IL185531A0 (enExample)
MX (1) MX2007010681A (enExample)
WO (1) WO2006096360A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011090345A3 (ko) * 2010-01-22 2011-12-29 성균관대학교산학협력단 플루페나믹산을 유효성분으로 포함하는 신규한 항생제 조성물

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
ZA200903135B (en) 2006-10-17 2010-08-25 Nuvo Res Inc Diclofenac gel
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
WO2010151241A1 (en) * 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
WO2012092523A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
HRP20201512T1 (hr) 2010-12-29 2020-12-11 Strategic Science & Technologies, Llc Liječenje erektilne disfunkcije i drugih indikacija
HRP20191806T1 (hr) 2011-05-03 2020-01-10 Aponia Laboratories, Inc. Transdermalni pripravci ibuprofena i postupci za njihovu uporabu
CN106573155A (zh) 2014-02-26 2017-04-19 鲁玛治疗公司 紫外光疗设备和方法
WO2017139514A1 (en) 2016-02-09 2017-08-17 Luma Therapeutics, Inc. Methods, compositions and apparatuses for treating psoriasis by phototherapy
US20200230082A1 (en) * 2017-07-11 2020-07-23 University Of Miami Topical acetaminophen formulations for itch relief
US20230398060A1 (en) * 2020-05-19 2023-12-14 Mig Usa, Llc Topical compositions and methods for treating pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
WO1987002891A1 (en) 1985-11-07 1987-05-21 Pfizer Inc. Compounds and method for the topical treatment of inflammation and pain
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011090345A3 (ko) * 2010-01-22 2011-12-29 성균관대학교산학협력단 플루페나믹산을 유효성분으로 포함하는 신규한 항생제 조성물
KR101141938B1 (ko) * 2010-01-22 2012-05-04 성균관대학교산학협력단 신규한 항생제 조성물 및 그람양성균의 치료 방법
US9238016B2 (en) 2010-01-22 2016-01-19 Sungkyunkwan University Foundation For Corporate Collaboration Antibiotic composition comprising flufenamic acid as an active ingredient

Also Published As

Publication number Publication date
BRPI0608077A2 (pt) 2009-11-10
EP1858503B1 (en) 2013-09-04
MX2007010681A (es) 2007-12-07
EP1858503A1 (en) 2007-11-28
CA2599968A1 (en) 2006-09-14
IL185531A0 (en) 2008-01-06
WO2006096360A1 (en) 2006-09-14
JP2008531693A (ja) 2008-08-14
AU2006220964A1 (en) 2006-09-14
ES2437201T3 (es) 2014-01-09

Similar Documents

Publication Publication Date Title
US20100158993A1 (en) Topical Gel Compositions
EP1858503B1 (en) Topical gels compositions
JP3356455B2 (ja) ケトプロフェンリジン塩を含む局所用親水性医薬組成物
CA2662434C (en) Topical nsaid compositions with increased solubility
US20140314815A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
JPH06100443A (ja) 水系ゲルのレチノイド服用形態
US4500511A (en) Antiinflammatory and analgesic gel
JP2000501429A (ja) 局所治療用および化粧用製剤の組成物基剤
US7795309B2 (en) Topical formulation including diclofenac, or a pharmaceutically acceptable salt thereof
JP2000143540A (ja) 非ステロイド系消炎鎮痛薬含有外用剤
US20050137164A1 (en) Diclofenac compositions for the treatment of skin disorders
EP3202420B1 (en) Transdermal pharmaceutical compositions comprising a serm
US20110281947A1 (en) Methods of administering diclofenac compositions for treating photodamaged skin
EP2019666B1 (en) Pharmaceutical preparations for transdermal use
ZA200707357B (en) Detection of very virulent infectious bursal disease virus
EP2233138A1 (en) Tape preparation comprising etodolac in ionic liquid form
JP2022188061A (ja) Ｖｅｇｆ阻害剤の局所投与による皮膚障害の処置
CN101541321A (zh) 局部用组合物
CN101151028A (zh) 局部用凝胶组合物
HK1119058A (en) Topical gels compositions
US20240299422A1 (en) Topical Cannabinoid Compositions and Methods for Treating Skin Diseases
WO2024245894A1 (en) (4r)-3-(4-fluoro-2-hydroxyphenyl)-4-methyl-4,5-dihydro-1h-pyrazole-1-carboximidamide hydrochloride and dermal formulations thereof
RU2624238C2 (ru) Лечение себореи
US20080221212A1 (en) Topical formulation
WO2018116190A1 (en) Topical sprayable compositions of ketorolac tromethamine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20071002

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid